DuPont and SkyCell force pharma logistics alliance

posted on 12th July 2018 by Justin Burns
DuPont and SkyCell force pharma logistics alliance

DuPont and SkyCell have formed a strategic alliance to collaborate on technical and market development in pharmaceutical logistics.

DuPont is the manufacturer of the Tyvek thermal cargo covers and SkyCell is a Swiss-based manufacturer of temperature-controlled containers for food and pharmaceuticals.

The companies said the alliance will lead to innovations in temperature monitoring, shipment tracking, asset management and ‘smart’ data-driven services.

Tyvek and Typar vice president and general manager, Christian Marx said: “DuPont is a firm believer in the potential of strategic alliances like this one where each party can leverage its respective strength for powerful solutions.

“There is a strong strategic fit between DuPont and SkyCell and we see this as an important step in complementing our Tyvek® Cargo Covers offering and expanding our market capability with high-performance solutions for an increasingly sophisticated pharmaceutical supply chain.”

Under the terms of the agreement DuPont will gain access to SkyCell’s remote temperature-management solutions and expertise and acquire marketing rights to the SkyCell portfolio of insulated shipping containers.

The SkyCell containers will be marketed by DuPont alongside its Tyvek products enabling the market-leader in cargo covers to provide an unrivalled breadth of high-tech temperature-management solutions to discerning customers.

SkyCell will be in a position to tap into the technical resource of DuPont and benefit from the DuPont global network especially in emerging markets and the Asia-Pacific region.

SkyCell chief executive officer, Richard Ettl said: “We are excited to be entering into the next stage of our journey by collaborating with DuPont Tyvek, a trusted provider of protection in pharmaceutical logistics.

“With a shared vision of better leveraging data in the supply chain of sensitive pharmaceuticals, this partnership will help us play our part in ensuring that medicines, vaccines and other health-related treatments get to the final patients in a safe, sustainable and timely manner.”